Charles Schwab’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-26,377
| Closed | -$86.8K | – | 3643 |
|
|
2023
Q2 | $86.8K | Sell |
26,377
-21,915
| -45% | -$66.2K | ﹤0.01% | 3359 |
|
|
2023
Q1 | $439K | Sell |
48,292
-491
| -1% | -$6.96K | ﹤0.01% | 2991 |
|
|
2022
Q4 | $572K | Buy |
48,783
+1,147
| +2% | +$20.2K | ﹤0.01% | 2963 |
|
|
2022
Q3 | $1.01M | Sell |
47,636
-1,413
| -3% | -$38.1K | ﹤0.01% | 2792 |
|
|
2022
Q2 | $1.19M | Sell |
49,049
-5,775
| -11% | -$197K | ﹤0.01% | 2731 |
|
|
2022
Q1 | $2.73M | Buy |
54,824
+1,452
| +3% | +$71.7K | ﹤0.01% | 2546 |
|
|
2021
Q4 | $3.75M | Buy |
53,372
+876
| +2% | +$73.8K | ﹤0.01% | 2492 |
|
|
2021
Q3 | $4.9M | Buy |
52,496
+1,309
| +3% | +$124K | ﹤0.01% | 2384 |
|
|
2021
Q2 | $5.14M | Buy |
51,187
+1,529
| +3% | +$149K | ﹤0.01% | 2342 |
|
|
2021
Q1 | $4.63M | Buy |
49,658
+2,912
| +6% | +$295K | ﹤0.01% | 2337 |
|
|
2020
Q4 | $3.86M | Buy |
46,746
+2,084
| +5% | +$178K | ﹤0.01% | 2346 |
|
|
2020
Q3 | $3.83M | Buy |
44,662
+29,558
| +196% | +$3.44M | ﹤0.01% | 2211 |
|
|
2020
Q2 | $1.41M | Buy |
15,104
+828
| +6% | +$45.6K | ﹤0.01% | 2536 |
|
|
2020
Q1 | $407K | Hold |
14,276
| – | – | ﹤0.01% | 2780 |
|
|
2019
Q4 | $592K | Buy |
14,276
+7,581
| +113% | +$166K | ﹤0.01% | 2762 |
|
|
2019
Q3 | $95K | Hold |
6,695
| – | – | ﹤0.01% | 3096 |
|
|
2019
Q2 | $235K | Buy |
6,695
+5,819
| +664% | +$316K | ﹤0.01% | 3066 |
|
|
2019
Q1 | $50K | Buy |
+876
| New | +$47.4K | ﹤0.01% | 3129 |
|
|
2018
Q2 | – | Sell |
-1,940
| Closed | -$204K | – | 3157 |
|
|
2018
Q1 | $204K | Hold |
1,940
| – | – | ﹤0.01% | 2989 |
|
|
2017
Q4 | $249K | Buy |
1,940
+513
| +36% | +$63.1K | ﹤0.01% | 2934 |
|
|
2017
Q3 | $165K | Hold |
1,427
| – | – | ﹤0.01% | 3036 |
|
|
2017
Q2 | $187K | Buy |
+1,427
| New | +$193K | ﹤0.01% | 3040 |
|
Other funds holding VBIV
PA
GAI
